We observed a striking downregulation in PDE4D7 expression between primary prostate cancer without tumour progression (Primary PCa, NP) and primary prostate cancer tissue with either progression to BCR (Primary PCa, BCR) or CR (Primary PCa, CR). This evidence concerns the gene BCR and prostate carcinoma.